Toward a hierarchical virtual screening and toxicity risk analysis for identifying novel CA XII inhibitors. - Elmira Nazarshodeh; Sajjad Gharaghani (Biosyst., 2017)

In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation. - Sedighe Sadat Jafaripour; Sajjad Gharaghani; Elmira Nazarshodeh; Shozeb Haider; Ali Akbar Saboury (Comput. Biol. Chem., 2020)